Literature DB >> 30026053

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors.

Eva Juengel1, Holger H H Erb2, Axel Haferkamp2, Jochen Rutz3, Felix K-H Chun3, Roman A Blaheta3.   

Abstract

Due to an increased understanding of molecular biology and the genomics of cancer, new and potent agents have been approved by the Food and Drug Administration (FDA) to fight this disease. However, all of these drugs cause severe side effects and resistance inevitably develops, re-activating tumor growth and dissemination. For this reason, patients turn to natural compounds as alternative or complementary treatment options, since it has been found that natural plant products may block, inhibit, or reverse cancer development. The present review focusses on the role of the natural compound sulforaphane (SFN) as an anti-tumor agent in urologic cancer. SFN is a natural compound found in cruciferous vegetables from the Brassicaceae family such as broccoli, cauliflower and cabbage. Several epidemiologic and clinical studies have documented chemopreventive properties of SFN, making it an interesting candidate for additive cancer treatment. SFN shows remarkable anti-tumor effects in vitro and in vivo without exerting toxicity. The review summarizes the current understanding of SFN and provides insights into its molecular mode of action with particular emphasis on epigenetic tumor control.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemoprevention; Dietary HDAC inhibitor; Sulphoraphane; Urologic tumors

Mesh:

Substances:

Year:  2018        PMID: 30026053     DOI: 10.1016/j.canlet.2018.07.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Synthesis and Evaluation of Functionalized Aryl and Biaryl Isothiocyanates against Human MCF-7 Cells.

Authors:  Claire C Fanta; Kaitlyn J Tlusty; Sarah E Pauley; Amanda L Johnson; Genevieve A Benjamin; Taylor K Yseth; Michaela M Bunde; Paul T Pierce; Shirley Wang; Peter F Vitiello; Jared R Mays
Journal:  ChemMedChem       Date:  2022-06-09       Impact factor: 3.540

2.  Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.

Authors:  Meng Yang; Qingqiong Luo; Xu Chen; Fuxiang Chen
Journal:  J Nanobiotechnology       Date:  2021-08-28       Impact factor: 10.435

3.  Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro.

Authors:  Hui Xie; Jochen Rutz; Sebastian Maxeiner; Timothy Grein; Anita Thomas; Eva Juengel; Felix K-H Chun; Jindrich Cinatl; Axel Haferkamp; Igor Tsaur; Roman A Blaheta
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

4.  Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines.

Authors:  Jochen Rutz; Sebastian Maxeiner; Timothy Grein; Marlon Sonnenburg; Salma El Khadir; Nino Makhatelashvili; Johanna Mann; Hui Xie; Jindrich Cinatl; Anita Thomas; Felix K-H Chun; Axel Haferkamp; Roman A Blaheta; Igor Tsaur
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

Review 5.  Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma.

Authors:  Hui Xie; Felix K-H Chun; Jochen Rutz; Roman A Blaheta
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 6.  Science and Healthy Meals in the World: Nutritional Epigenomics and Nutrigenetics of the Mediterranean Diet.

Authors:  Fabio Caradonna; Ornella Consiglio; Claudio Luparello; Carla Gentile
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

7.  Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.

Authors:  Saira Justin; Jochen Rutz; Sebastian Maxeiner; Felix K-H Chun; Eva Juengel; Roman A Blaheta
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

Review 8.  Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives.

Authors:  Mikołaj Wołącewicz; Rafał Hrynkiewicz; Ewelina Grywalska; Tomasz Suchojad; Tomasz Leksowski; Jacek Roliński; Paulina Niedźwiedzka-Rystwej
Journal:  Cancers (Basel)       Date:  2020-05-07       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.